BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
5.69
+0.42 (7.97%)
Jun 6, 2025, 2:54 PM - Market open
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $18.87 million as of June 6, 2025. Its market cap has decreased by -63.87% in one year.
Market Cap
18.87M
Enterprise Value
5.39M
1-Year Change
-63.87%
Ranking
Category
Stock Price
$5.69
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $18.87M, a decrease of -44.18%. That is a compound annual growth rate of -3.61%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.28B |
| Johnson & Johnson | 368.73B |
| AbbVie | 331.01B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 273.03B |
| Abbott Laboratories | 230.51B |
| Novartis AG | 229.87B |
| AstraZeneca | 226.47B |